Genprex, Inc.

GNPX

Genprex, Inc.

GNPX

Insider Sentiment (TTM):

Last Purchase:2023-04-21Last Sale:2026-04-14Shares Purchased (TTM):0Shares Sold (TTM):8

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:86,292Shares Outstanding:6,951,999Institutional Ownership Pct.:1.24%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	15	18	8	1	1	3	2	1	2	8	7	12
Assets Current
Assets Current	16	19	8	2	2	4	2	2	4	9	8	13
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	0	0	2	1	1	1
Property Plant And Equipment Net	-	-	0	-	-	-	0	0	0	0	0	0
Other Assets
Other Assets Noncurrent
Other Assets Noncurrent	1	2	2	2	2	2	2	2	2	3	3	4
Deposits Assets Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Assets	17	20	10	4	4	6	4	4	7	13	11	17
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	-	0	0	0	1	1	1
Accounts Payable And Accrued Liabilities Current	0	2	1	2	1	2	1	1	1	2	1	1
Liabilities Current
Liabilities Current	2	3	2	3	2	2	3	2	2	4	3	4
Other Liabilities Current	2	2	1	1	2	1	1	1	1	2	2	3
Liabilities Noncurrent
Derivative Liabilities	0	0	0	0	-	-	0	-	-	-	-	-
Liabilities	2	3	2	3	-	-	3	-	-	-	-	-
Accounts Receivable Net Current	-	-	-	-	-	-	-	0	0	0	0	0
Preferred Stock Value	0	0	0	0	0	0	0	-	-	-	0	0
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity	15	17	8	1	1	4	2	2	4	9	7	12
Additional Paid In Capital	195	192	179	168	165	163	156	152	150	148	141	140
Retained Earnings Accumulated Deficit	-180	-175	-171	-167	-163	-159	-155	-150	-146	-140	-134	-128
Liabilities And Stockholders Equity	17	20	10	4	4	6	4	4	7	13	11	17
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	-	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	1	9	3	1	1	0	0	0	-	0	0	0
Shares Outstanding	1	9	3	1	28	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-23.97%	-32.31%	-67.63%	-	-	-	-	-	-	-	-	-
2025	4.35%	-5.80%	-16.30%	6.48%	-11.11%	-46.57%	-24.15%	-59.59%	-39.95%	-42.37%	-53.62%	-66.55%
2024	-2.20%	-24.15%	-37.33%	-51.76%	-73.87%	39.44%	-35.00%	-47.63%	-61.31%	23.91%	19.57%	14.78%
2023	-	-	-	13.36%	-27.62%	-50.33%	-1.70%	0.85%	-37.13%	-25.59%	-25.93%	-31.99%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.77	5.61	3.84	0.67	0.84	1.94	0.83	0.86	1.95	2.42	2.31	2.96
Quick Ratio	6.47	5.38	3.60	0.43	0.55	1.62	0.64	0.66	1.09	2.16	2.07	2.70
Working Capital	13.50M	15.45M	6.18M	-836.61K	-380.15K	2.02M	-426.70K	-324.79K	2.14M	5.42M	4.28M	8.52M
Leverage & Debt
Debt to Equity	0.16	0.20	0.28	3.64	1.75	0.55	1.55	1.35	0.52	0.43	0.44	0.35
Debt Ratio	0.14	0.17	0.22	0.78	0.64	0.36	0.61	0.57	0.34	0.30	0.30	0.26
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Free Cash Flow Per Share TTM	-35.05	-2.06	-16.42	-14.36	-393.18	-54.98	-223.86	-272.01	-499.89	-715.99	-906.97	-844.29
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-6.06%	-13.71%	-24.12%	-24.94%	-32.82%	-29.84%	-30.69%	-27.80%	-12.42%	-0.03%	29.99%	31.24%
EPS Growth (1Y)	-94.99%	-96.21%	-93.48%	-93.09%	15.14%	-92.56%	-76.34%	-70.19%	-47.36%	-23.59%	13.94%	8.94%
Valuation Metrics
P/E TTM	-0.33	-16.55	-2.21	-8.29	-0.36	-4.25	-3.51	-1.23	-3.43	-3.84	-8.97	-15.97
P/B TTM	0.37	16.35	4.51	184.13	4.55	21.27	46.36	16.74	20.63	12.12	37.33	40.82
Market Cap	5.40M	276.83M	35.91M	141.38M	6.33M	82.29M	75.11M	27.88M	89.66M	106.09M	276.83M	502.34M
Enterprise Value	-9.75M	258.78M	28.08M	140.27M	4.98M	78.82M	73.50M	26.39M	87.20M	97.87M	270.09M	490.63M
Calculated Values
Free Cash Flow TTM	-16.59M	-14.29M	-15.31M	-10.92M	-9.92M	-16.79M	-17.94M	-19.04M	-21.62M	-23.17M	-24.81M	-24.40M
Net Debt	-15.15M	-18.05M	-7.83M	-1.10M	-1.35M	-3.47M	-1.60M	-1.49M	-2.46M	-8.22M	-6.74M	-11.71M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-14Sale

Owner: Longnecker, Brent M

Title: -

Shares: 8

Price/Share: $1.23

Value: $9.84

Shares Owned: 9,157

Relationship: Director

Ownership: Direct

2023-04-21Purchase

Owner: Varner, John Rodney

Title: Chairman, President and CEO

Shares: 19,000

Price/Share: $1.06

Value: $20,140.00

Shares Owned: 20,800

Relationship: Director,Officer

Ownership: Indirect

2023-04-21Purchase

Owner: Vaczy, Catherine M

Title: EVP GC Chief Strategy Officer

Shares: 20,000

Price/Share: $1.07

Value: $21,400.00

Shares Owned: 265,000

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-14	Longnecker, Brent M	Director	-	Direct	Sale	8	1.23	$9.84	9,157	4
2023-04-21	Varner, John Rodney	Director,Officer	Chairman, President and CEO	Indirect	Purchase	19,000	1.06	$20,140.00	20,800	4
2023-04-21	Vaczy, Catherine M	Officer	EVP GC Chief Strategy Officer	Direct	Purchase	20,000	1.07	$21,400.00	265,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

1.24%

Inst. Shares: 86,292

Shares Outstanding: 6,951,999

2025-12-31

0.77%

Inst. Shares: 7,153

Shares Outstanding: 932,730

2025-09-30

178.06%

Inst. Shares: 1,354,182

Shares Outstanding: 760,502

2025-06-30

113.68%

Inst. Shares: 627,366

Shares Outstanding: 551,879

2025-03-31

102.34%

Inst. Shares: 312,456

Shares Outstanding: 305,326

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	86,292	6,951,999	1.24%
2025-12-31	7,153	932,730	0.77%
2025-09-30	1,354,182	760,502	178.06%
2025-06-30	627,366	551,879	113.68%
2025-03-31	312,456	305,326	102.34%
2024-12-31	193,759	80,139	241.78%
2024-09-30	153,908	70,013	219.83%
2024-06-30	270,707	43,239	-
2024-03-31	142,948	32,365	-
2023-12-31	4,518,645	27,355	-
2023-09-30	6,512,018	28,903	-
2023-06-30	3,798,942	25,990	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Genprex, Inc. (GNPX) — SEC Financial Statements & Analysis

Genprex, Inc. (GNPX) is a pharmaceutical preparations company, incorporated in TX. Genprex, Inc. trades on Nasdaq as: GNPX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Genprex, Inc. reported a Debt-to-Equity ratio of 0.16x, a Price-to-Book (P/B) ratio of 0.37x (TTM), at a market cap of $5.40M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.16x
P/B TTM: 0.37x
Market Cap: $5.40M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Genprex, Inc. in?

Genprex, Inc. (GNPX) operates in the Pharmaceutical Preparations industry.

What is GNPX's market cap?

Genprex, Inc. (GNPX) has a market capitalization of $5.40M as of 2026-06-30.

What exchange does GNPX trade on?

Genprex, Inc. (GNPX) trades on the Nasdaq.

Where is Genprex, Inc. incorporated?

Genprex, Inc. is incorporated in TX.

Genprex, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Genprex, Inc. (GNPX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Genprex, Inc. (GNPX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.